The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history
Open accessAbstract
The goals of this study were to determine the rate of recurrent primary biliary cirrhosis (PBC) after orthotopic liver transplantation (OLT) based on strict morphologic criteria and to evaluate histologic progression of recurrent PBC over time. Strict criteria for PBC recurrence were established as the presence of a florid duct lesion or destructive lymphocytic cholangitis within a dense portal infiltrate. Of the 784 OLTs performed at the Mayo Clinic during the first 12 years of the program, 100 met criteria for the PBC study group, and 35 met criteria for the control group. Strict histologic criteria for recurrent PBC were observed in 17 of 100 (17%) study patients (14 with florid duct lesion, 3 with destructive lymphocytic cholangitis within dense portal infiltrate). Mean follow-up for the PBC group was 4.7 years (range, 1.0 to 13.8). Mean time to recurrence was 3.7 years (median, 3.1; range, 0.3 to 7.9). In those who met strict criteria for recurrent PBC, 2 of 17 progressed to septal fibrosis (stage 3). No florid duct lesions, destructive lymphocytic cholangitis, or septal fibrosis were observed in the control group. Other less specific morphologic features of PBC (portal infiltrates, plasma cells, dense lymphoplasmacytic infiltrates, and lymphocytic cholangitis) were also evaluated in the course of this study. Based on strict criteria, a conservative histologic estimate of the rate of recurrent PBC is 17% with a mean of 4.7 years of follow-up. When criteria for histologic recurrence are expanded to include moderate lymphocytic cholangitis with lymphoplasmacytic portal infiltrate, the recurrence rate of PBC is estimated as 26%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some 20% to 30% of patients with PBC who undergo transplantation develop recurrent disease over 10 years, and up to 50% do so by 20 years of follow-up.”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [257]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fortunately, recurrent PBC infrequently affects long-term patient or graft survival.(258)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [258]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The median time to recurrence is 3 to 6 years.(256,257)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [257]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“patients on UDCA post liver transplantation appear to have lower recurrence rates compared with patients who did not receive UDCA post transplant (21% versus 62%; P = 0.004).(257)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [257]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a recent study, a higher Model for End-Stage Liver Disease score at the time of wait list registration was also associated with increased recurrence rates.(257)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [257]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garcia, R. F. L., Garcia, C. E., McMaster, P., & Neuberger, J. (2001) · Hepatology · doi:10.1053/jhep.2001.20894 · Cited by 254
Recurrence of Primary Biliary Cirrhosis after Liver Transplantation
Neuberger, J., Portmann, B., Macdougall, B. R. D., Calne, R., & Williams, R. L. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201073060101 · Cited by 251
Portmann, B. C., Pópper, H., Neuberger, J., & Williams, R. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90001-0 · Cited by 135
Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis
Polson, R. J., Portmann, B., Neuberger, J., Calne, R., & Williams, R. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90643-4 · Cited by 111
de Water, J. V. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008903379 · Cited by 104
Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation
Balan, V., Batts, K. P., Porayko, M. K., Krom, R. A. F., Ludwig, J., & Wiesner, R. H. (1993) · Hepatology · doi:10.1002/hep.1840180617 · Cited by 102
Self-citationde Water, J. V., Gerson, L. B., Ferrell, L. D., et al. (1996) · Hepatology · doi:10.1002/hep.510240517 · Cited by 96
Liver transplantation for primary biliary cirrhosis: A long-term pathologic study
Khettry, U., Anand, N., Faul, P. N., Lewis, D. W., Pomfret, E. A., Pomposelli, J. J., Jenkins, R. L., & Gordon, F. D. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.36392 · Cited by 94
Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression
Dmitrewski, J., Hübscher, S. G., Mayer, A. D., & Neuberger, J. M. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80001-8 · Cited by 92
Ultrastructural lesions of bile ducts in primary biliary cirrhosis
Bernuau, D., Feldmann, G., Degott, C., & Gisselbrecht, C. (1981) · Human Pathology · doi:10.1016/s0046-8177(81)80081-0 · Cited by 78
Wong, P. Y. N., Portmann, B., O'Grady, J. G., Devlin, J., Hegarty, J. E., Tan, K. C., & Williams, R. L. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80206-5 · Cited by 74
Sebagh, M., Farges, O., Dubel, L., Samuel, D., Bismuth, H., & REYNES, M. (1998) · Transplantation · doi:10.1097/00007890-199805270-00008 · Cited by 67
Pathogenesis of primary biliary cirrhosis
Jones, D. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00270-8 · Cited by 62
Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis
Wiesner, R. H., Grambsch, P. M., Lindor, K. D., Ludwig, J., & Dickson, E. R. (1988) · Hepatology · doi:10.1002/hep.1840080339 · Cited by 61
Self-citationRussell, S. M. (1992) · Gastroenterology Nursing · doi:10.1097/00001610-199202000-00016 · Cited by 44
Clinical significance of recurrent primary biliary cirrhosis after liver transplantation
Knoop, M., Bechstein, W. O., Schrem, H., Lobeck, H., Hopf, U., & Neuhaus, P. (1996) · Transplant International · doi:10.1111/j.1432-2277.1996.tb01586.x · Cited by 21
Flagged first, then by citations
Research works printed but not linked: 1
- Hubscher, 1992, Hepatology, 16, 545
Cited by
Sorted by citations
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Tsukada, S., Parsons, C. J., & Rippe, R. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 355
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61965-4 · Cited by 334
Recurrence of autoimmune liver disease after liver transplantation: A systematic review
Gautam, M., Cheruvattath, R., & Balan, V. (2006) · Liver Transplantation · doi:10.1002/lt.20910 · Cited by 272
Metadata
- Authors
- Sylvestre, P. B., Batts, K. P., Burgart, L. J., Poterucha, J. J., & Wiesner, R. H.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Sylvestre, Pamela B.
- ORCID
- Sylvestre, Pamela B.
- Venue
- Liver Transplantation
- Published
- 2003-10
- Volume
- 9
- Issue
- 10
- Pages
- 1086-1093
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2086612029
- Cited by
- 148
- References
- 15
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 2 · 2018: 11 · 2017: 7 · 2016: 5 · 2015: 12 · 2014: 6 · 2013: 4 · 2012: 5
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Liver Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, recurrence, septal fibrosis, histological criteria, natural history (disease), lymphoplasmacytic infiltration
- MeSH terms
- Bile Ducts, Cholangitis, Fibrosis, Follow-Up Studies, Humans, Liver Cirrhosis, Biliary, Plasma Cells, Postoperative Complications, Recurrence, Incidence, Liver Transplantation, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
